Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

NCT01871571 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Mucinous Adenocarcinoma of the Rectum
Signet Ring Adenocarcinoma of the Rectum
Stage IIA Rectal Cancer
Stage IIB Rectal Cancer
Stage IIC Rectal Cancer
Stage IIIA Rectal Cancer
Stage IIIB Rectal Cancer
Stage IIIC Rectal Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: oxaliplatin
DRUG: leucovorin calcium
DRUG: fluorouracil
OTHER: laboratory biomarker analysis

Sponsor

University of Southern California

Collaborators

[object Object]